Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 11, 2026 11:10 ET | Source: Kessler Topaz Meltzer & Check LLP

Kessler Topaz Meltzer & Check, LLP - Gemini Space Station, Inc. Investors: May 18, 2026, Deadline in Securities Fraud Class Action Lawsuit

Did you buy GEMI Class A common stock and/or securities between September 12, 2025, and February 17, 2026? Affected GEMI Investor Summary Who: Gemini Space Station, Inc. (NASDAQ: GEMI)What:...
April 11, 2026 11:00 ET | Source: Bragar Eagel & Squire

Bragar Eagel & Squire, P.C. Reminds Eos Energy Enterprises, Inc. (NASDAQ: EOSE) Investors to Contact the Firm Regarding Their Rights Before May 6th

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Eos (EOSE) To Contact Him Directly To Discuss Their Options If you purchased or...
April 11, 2026 10:00 ET | Source: Klaiyi Hair

Upcoming National Women’s Health Week: Promoting Scalp Care and Breathable Wig Solutions

To support women on their health journey, Klaiyi Hair offers skin-friendly wigs designed to protect and nourish the scalp while offering versatile styling.
April 11, 2026 09:00 ET | Source: TitanPlay

TitanPlay Highlights Early-Stage Approach to Responsible Gambling in Ontario

TORONTO, April 11, 2026 (GLOBE NEWSWIRE) -- TitanPlay, a regulated iGaming operator in Ontario’s licensed market, today outlined its approach to responsible gambling, highlighting that effective...
April 11, 2026 08:31 ET | Source: SOHO Holding Group

Fußballbegeisterung wächst: SOHO Holdings kooperiert für die Saison 2026 mit der Jiangsu Football City League

NANJING, China, April 11, 2026 (GLOBE NEWSWIRE) -- Am 11. April fällt der Startschuss für die Saison 2026 der Jiangsu Football City League („Su Chao“), die von der SOHO Holding Group als Co-Sponsor...
April 11, 2026 07:00 ET | Source: BioNTech SE

BioNTechs und DualityBios Antikörper-Wirkstoff-Konjugat-Kandidat Trastuzumab Pamirtecan zeigte klinisch relevante Wirksamkeit bei Patientinnen mit rezidivierendem HER2-exprimierendem Gebärmutterkrebs

BioNTech gab heute positive Ergebnisse aus der primären Analyse einer Phase-2-Kohorte mit Trastuzumab Pamirtecan bei HER2+ Gebärmutterkrebs bekannt.
April 11, 2026 07:00 ET | Source: BioNTech SE

BioNTech and DualityBio’s Antibody-Drug Conjugate Trastuzumab Pamirtecan Demonstrated Clinically Meaningful Efficacy in Patients with HER2-Expressing, Recurrent Endometrial Cancer

BioNTech today announced positive results from the primary analysis of a Phase 2 cohort evaluating trastuzumab pamirtecan in HER2+ endometrial cancer.
April 11, 2026 06:09 ET | Source: Chunhyang Festival

'The Charm of Chunhyang Captivates the World' 96th Namwon Chunhyang Festiva Kicks Off on April 30

NAMWON, KOREA, April 11, 2026 (GLOBE NEWSWIRE) -- The 96th Namwon Chunhyang Festival will take place from April 30 to May 6, 2026, in Namwon, South Korea, according to the festival organizers....
April 11, 2026 06:00 ET | Source: Garvee Innovation Inc.

City Furniture and GARVEE Explore Omnichannel Retail Collaboration in North America

City Furniture and GARVEE Explore Omnichannel Retail Collaboration in North America
April 11, 2026 05:42 ET | Source: Cookiy AI

Cookiy Introduces a User Research Suite That Enables Any AI to Talk to Real People

SAN FRANCISCO, April 11, 2026 (GLOBE NEWSWIRE) -- Cookiy AI today launched a suite of user research tools (Cookiy Skill, CLI, and MCP Server) that enable any AI platform to reach real people...